Kyowa Hakko Kirin Korea Overview

  • Year Founded
  • 1991

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A
  • (Cancelled)

  • Financing Rounds
  • 3

Kyowa Hakko Kirin Korea General Information

Description

Manufacturer of ethical drugs and specialty pharmaceuticals based in Seoul, South Korea. The company is primarily involved in the development and sale of ethical drugs including Grasin, Neulasta, and Romiplate, a group of products in the hematologic field, and Nesp, Regpara, and Olkadia, a group of products in the nephrology field.

Contact Information

Formerly Known As
Jeil-Kirin Pharmaceutical
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 430 Nonhyeon-ro, 11th Floor, Asia Tower Building
  • Gangnam-gu
  • Seoul, 135-784
  • South Korea
Primary Industry
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • 430 Nonhyeon-ro, 11th Floor, Asia Tower Building
  • Gangnam-gu
  • Seoul, 135-784
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kyowa Hakko Kirin Korea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kyowa Hakko Kirin Korea‘s full profile, request access.

Request a free trial

Kyowa Hakko Kirin Korea Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kyowa Hakko Kirin Korea‘s full profile, request access.

Request a free trial

Kyowa Hakko Kirin Korea FAQs

  • When was Kyowa Hakko Kirin Korea founded?

    Kyowa Hakko Kirin Korea was founded in 1991.

  • Where is Kyowa Hakko Kirin Korea headquartered?

    Kyowa Hakko Kirin Korea is headquartered in Seoul, South Korea.

  • What industry is Kyowa Hakko Kirin Korea in?

    Kyowa Hakko Kirin Korea’s primary industry is Pharmaceuticals.

  • Is Kyowa Hakko Kirin Korea a private or public company?

    Kyowa Hakko Kirin Korea is a Private company.

  • What is Kyowa Hakko Kirin Korea’s current revenue?

    The current revenue for Kyowa Hakko Kirin Korea is .

  • Who are Kyowa Hakko Kirin Korea’s investors?

    Jeil Pharmaceutical Holding has invested in Kyowa Hakko Kirin Korea.

  • When was Kyowa Hakko Kirin Korea acquired?

    Kyowa Hakko Kirin Korea was acquired on 07-Oct-2024.

  • Who acquired Kyowa Hakko Kirin Korea?

    Kyowa Hakko Kirin Korea was acquired by Kyowa Kirin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process